Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/5mL 10mg/5mL 30mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride4mg/5mL 15mg/5mL60mg/5mL syrup (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 45mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride4mg/5mL 30mg/5mL60mg/5mL syrup (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+codeine phosphate+phenylpropanolamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + phenylpropanolamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + pseudoephedrine + acetaminophen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + phenylephrine+ phenylpropanolamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + dextromethorphan hydrobromid + phenylpropanolamine hydrochl 2mg/10mg/12.5mg liquid (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + guaifenesin + hydrocodone bitartrate 2mg/200mg/5mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+hydrocodone bitartrate+pseudoephedrine hydrochlorid 2mg/1.7mg/30mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + hydrocodone bitartrate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate 2mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate 10mg/1mL injection 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing brompheniramine maleate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate 10mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + pseudoephedrine hydrochlorid 12mg/120mg capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine maleate 6 mg oral tablet |
Has basis of strength substance (attribute) |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Brompheniramine maleate 6 mg oral tablet |
Has precise active ingredient |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution |
Has precise active ingredient |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely brompheniramine maleate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely brompheniramine maleate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution |
Has precise active ingredient |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution |
Has precise active ingredient |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet |
Has precise active ingredient |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brompheniramine maleate 3 mg and caffeine 30 mg and paracetamol 325 mg oral tablet |
Has basis of strength substance (attribute) |
True |
maléate de bromphéniramine |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |